These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15334014)

  • 21. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era.
    Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS
    Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Intraocular Infections in HIV.
    Testi I; Mahajan S; Agrawal R; Agarwal A; Marchese A; Curi A; Khairallah M; Leo YS; Nguyen QD; Gupta V
    Ocul Immunol Inflamm; 2020 Oct; 28(7):1099-1108. PubMed ID: 32162992
    [No Abstract]   [Full Text] [Related]  

  • 30. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
    Gangaputra S; Drye L; Vaidya V; Thorne JE; Jabs DA; Lyon AT;
    Am J Ophthalmol; 2013 Feb; 155(2):206-212.e5. PubMed ID: 23068916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads.
    Rothova A; Schneider M; de Groot-Mijnes JD
    Ophthalmology; 2008 Nov; 115(11):2062-4. PubMed ID: 18562005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    Arq Neuropsiquiatr; 2005 Dec; 63(4):907-13. PubMed ID: 16400403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R; Walker B
    JAMA; 1999 Nov; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract]   [Full Text] [Related]  

  • 36. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).
    Roels P
    Optometry; 2004 Oct; 75(10):624-8. PubMed ID: 15508863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular and plasma HIV-1 RNA loads and HIV uveitis.
    Pathanapitoon K; Riemens A; Kongyai N; Sirirungsi W; Leechanachai P; Ausayakhun S; Kalinina Ayuso V; Kunavisarut P; de Groot-Mijnes JD; Rothova A
    AIDS; 2011 Jan; 25(1):81-6. PubMed ID: 21099669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Margolis TP
    Surv Ophthalmol; 2000; 44(5):455. PubMed ID: 10809654
    [No Abstract]   [Full Text] [Related]  

  • 39. Polymerase chain reaction analysis of aqueous humor specimens in the diagnosis of cytomegalovirus retinitis in AIDS patients.
    Mao F; Sun H; Li D; Wang S; Lu D
    Eur J Ophthalmol; 2020 Jul; 30(4):738-742. PubMed ID: 30968705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytomegalovirus retinitis in pediatric patients with AIDS receiving highly active antiretrovirus therapy].
    Dimantas MA; Finamor LP; Ewert V; Nakanami C; Muccioli C
    Rev Assoc Med Bras (1992); 2004; 50(3):320-3. PubMed ID: 15499487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.